\
Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Turning the Tide on Cancer

Investing in Cardiff Oncology to Provide New Treatment Options for Cancers with the Greatest Medical Need

Stock Quote

NASDAQCRDF
$4.58
NASDAQCRDF
Open
$5.62
Change
-$1.56 (-25.44%)
Day's Range
$4.55 - $5.66
52-Week Range
$4.88 - $14.98
Volume
3.7M
Market Cap
$192.1M